Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Cancer Immunol Res. 2019 Nov 7;8(1):70–80. doi: 10.1158/2326-6066.CIR-19-0545

Table 2.

Toxicity profile.

Grade 1 / 2 Grade 3
n (%) n (%)
Dermatologic – Injection Site
Pain 23 92 - -
Swelling 7 28 - -
Erythema 19 76 - -
Pruritus 12 48 - -
Granuloma 16 64 - -
Ecchymosis 4 16 - -
Cellulitis 1 4 - -
Constitutional
Fever/Chills 17 68 - -
Fatigue 18 72 - -
Malaise 15 60 - -
Musculoskeletal
Myalgias 13 52 - -
Arthralgias 5 20 - -
Neurologic
Dizziness 2 8 - -
Headache 8 32 - -
Insomnia 1 4 - -
Anxiety 2 8 - -
Respiratory/ENT
Cough 5 20 - -
Sore Throat 2 8 - -
Congestion/Coryza 5 20 - -
Gastrointestinal
Abdominal Discomfort 2 8 - -
Nausea 1 4 - -
Loose Bowel Movements 1 4 - -
Cardiac
Coronary Artery Disease - - 1 4